From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

moxetumomab pasudotox   Click here for help

GtoPdb Ligand ID: 7675

Synonyms: CAT-8015 | GCR-8015 | HA22 | Lumoxiti® | moxetumomab pasudotox-tdfk
Approved drug Immunopharmacology Ligand
moxetumomab pasudotox is an approved drug (FDA (2018), EMA (2021))
Compound class: Antibody
Comment: Peptide sequence information for this antibody is available from its IMGT/mAb-DB link. The moxetumomab monoclonal has been mutated to increase affinity for CD22 [6] (patent WO2003027135[1]), and the antibody is fused to a 38 KDa fragment of Pseudomonas exotoxin-A (PE38) [2,4] (patent US7982011 [5]). The Uniprot accession for Pseudomonas exotoxin-A is P11439.
Click here for help
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes. US FDA (2018)  |  EU EMA (2021)
International Nonproprietary Names Click here for help
INN number INN
9236 moxetumomab pasudotox
Synonyms Click here for help
CAT-8015 | GCR-8015 | HA22 | Lumoxiti® | moxetumomab pasudotox-tdfk
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 198
Other databases
ChEMBL Ligand CHEMBL1743043
GtoPdb PubChem SID 223366010
Search PubMed clinical trials moxetumomab pasudotox
Search PubMed titles moxetumomab pasudotox
Search PubMed titles/abstracts moxetumomab pasudotox
Wikipedia Moxetumomab pasudotox